[Methods for in vitro studies of antibiotic combinations. Indications and limits]. 1987

A Thabaut, and M Meyran
Hôpital d'instruction des armées Bégin, Saint-Mandé.

Several methods are available in the bacteriology laboratory to study the antibacterial effect of antibiotic combinations. With "end point" methods, results are read and interpreted after 18 or 24 hours of incubation. Amongst these methods, gel diffusion is technically easy but gives only qualitative results. Respective concentrations in the interaction zone cannot be evaluated and are unrelated to concentrations obtained in vivo. In liquid medium, the "checker board" method offers the possibility of combining a large number of concentrations. Interpretation may be graphic or mathematical. It is often arbitrary. But above all these methods fail to recognize events which occur during the 18 or 24 hours of incubation. Kinetic methods can be used to evaluate the kinetics of bactericidal action in relation to time and hence to compare the rapidity and degree of the bactericidal action of antibiotics used alone or in combination. However, only a limited number of concentrations can be studied. During the evaluation of a new antibiotic all methods must be tried to determine the possible synergistic or antagonistic effects of combinations regarding bacteria with known different resistance mechanisms. The broad outline thus obtained serves as a prescribing base for combinations. Bactericidal effect should be confirmed by a kinetic method where the concentrations in contact with the bacterial inoculum are selected in relation to presumed concentrations obtained at the site of infection.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D004058 Diffusion The tendency of a gas or solute to pass from a point of higher pressure or concentration to a point of lower pressure or concentration and to distribute itself throughout the available space. Diffusion, especially FACILITATED DIFFUSION, is a major mechanism of BIOLOGICAL TRANSPORT. Diffusions
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria

Related Publications

A Thabaut, and M Meyran
May 1986, The American journal of medicine,
A Thabaut, and M Meyran
November 1976, Revue medicale de la Suisse romande,
A Thabaut, and M Meyran
March 1986, The Journal of antimicrobial chemotherapy,
A Thabaut, and M Meyran
August 1987, The Journal of antimicrobial chemotherapy,
A Thabaut, and M Meyran
June 1968, Applied microbiology,
A Thabaut, and M Meyran
November 1968, Dental Cadmos,
A Thabaut, and M Meyran
January 1992, Pediatrie (Bucharest, Romania),
A Thabaut, and M Meyran
January 1961, Pathologie et biologie,
A Thabaut, and M Meyran
January 2009, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer,
A Thabaut, and M Meyran
July 1981, Archives des maladies du coeur et des vaisseaux,
Copied contents to your clipboard!